INTRODUCTION
Through large randomised controlled trials (RCTs), carotid endarterectomy (CEA) has been positioned as a gold standard of treatment in patients with carotid artery stenosis to prevent ischemic stroke [1] [2] [3] [4] . Along with the advancement of endovascular treatment, carotid artery stenting (CAS) was introduced as a potential alternative to CEA during the past two decades. Possible benefits of CAS are less invasiveness (available in patients with high-risk morbidity, quicker recovery, lower wound complication), lower incidence of cranial nerve injury, coverage of entire length of carotid lesion, feasible in inaccessible lesion by CEA, feasibility in hostile neck (prior neck surgery or radiation) [5] .
Among several RCTs comparing CEA vs. CAS in patients with atherosclerotic carotid disease, some reported the non-inferiority of CAS to CEA [6] , while others failed to prove it [7, 8] . And some studies are still ongoing [9] [10] [11] .
Therefore, current practice guidelines recommend CAS as a possible alternative treatment to CEA only in patients with severe carotid stenosis and high operative risk [12, thesurgery.or.kr
13].
In this study, we aimed to investigate early and midterm outcomes of CAS in our hospital and to compare them with those of CEA. And we attempted to determine the risk factors of stroke after CAS. was considered likely to be an ulcer. During pre-treatment evaluation, all patients were categorized into high or low risk group. High risk was defined as clinically significant cardiac disease (congestive heart failure, unstable angina or need for urgent heart surgery), severe pulmonary disease, high lesion above the 2nd cervical vertebral body, previous radical neck surgery or ipsilateral carotid surgery, previous cervical radiation, contralateral recurrent laryngeal nerve palsy, presence of a tracheostomy stoma, contralateral carotid occlusion. For high-risk group, CAS was preferred. CAS was performed in 42 patients (CAS group, 38%) and CEA was done in 69 patients (CEA group, 62%).
METHODS
During CAS, predilatation was done in all patients.
Brain protection device (BPD; FilterWire EZ system, Boston Scientific Co., Natick, MA, USA) was used in 41 patients (98%). Self-expendable stents were inserted in all cases; Closed-cell type (WALLSTENT, Boston Scientific Fisher's exact test. Fisher's exact test. 
RESULTS
Patient demographic and clinical data are demonstrated in Table 1 . CAS group was older than CEA group (mean age, 70 vs. 66; P = 0.001, t-test) and coronary artery disease was more common in CAS group (29% vs. 13%, P = 0.043, chi-square test). There was no difference in other variables between the 2 groups. The mean follow-up duration was 25 months (range, 1 to 70 months). There was no 30-day mortality in both groups.
Regarding mid-term outcomes, 1-year, 3-year freedom from ipsilateral stroke was 90%, 83% in CAS group and thesurgery.or.kr 99%, 99% in CEA group (P = 0.007, log-rank test, Fig. 1 vs. 20.1% in 1-year major adverse events, P = 0.004 for non-inferiority) [6] . Recently, authors reported no significant difference in 3-year outcomes between 2 groups, such as freedom from major adverse event, freedom from death and freedom from stroke [14] . [7] . However, after up to 4-year follow-up, the risk of ipsilateral stroke was similar in both groups after periprocedural period [15] . The authors concluded that CAS is as effective as CEA for middle-term prevention of ipsilateral stroke, but the safety of CAS needs to be improved.
The Stent-Supported Percutaneous Angioplasty of the Carotid Artery versus Endarterectomy (SPACE) trial also reported equivalent 2-year results of CAS compared with CEA even though it had failed to prove non-inferiority of CAS for the 30-day results [16] . CAS group also showed higher risk of stroke, death, or procedural myocardial infarction in the intention-to-treat analysis (8.5% vs. 5.2%; RR, 1.69; CI, 1.16 to 2.45) on short-term (≤ 120 days) results of the International Carotid Stenting Study that were recently reported [17] .
In our study, perioperative stroke rates after CAS were higher than we expected (9% in asymptomatic patients, 10% in symptomatic patients and 10% in total patients). It was higher than CEA group, although it was not statistically significant (10% vs. 1%, P = 0.067). It is assumed that the small sample size caused type II error. However, after perioperative period, the Kaplan-Meier curves of CAS and CEA groups are almost parallel as in the EVA-3S and SPACE study. This means mid-term stroke risk is similar between 2 groups and CAS can be a potential alternative to CEA if perioperative complications of CAS are reduced.
One of the causes which might explain the high periprocedural stroke rate after CAS is plaque instability.
During CEA, not only plaque morphology but also plaque natures are visualized: smooth wall vs. irregular wall, soft plaque vs. hard plaque, ulcerative lesion, calcified lesion and plaque with hemorrhage. The vulnerable plaque is generally described as having a lipid core with a fibrous cap with thinning of the cap and inflammation in the shoulder region of the plaque [18] . In particular, when CAS is performed on vulnerable plaque or ulcerative plaque, there will be a high risk of embolization. Although a BPD is used, the guide wire and the device should be passed the lesion before. In this study, early stoke occurred more often in patients with plaque ulcers than without, even though it failed to make a significant difference (17% Another issue is NBLs after treatment. On meta-analysis of 32 studies, the incidence of any NBLs on DW-MRI was significantly higher after CAS than after CEA (37% vs.
10%, P ＜ 0.01) [26] . And authors reported that the use of BPD (33% vs. 45% without, P ＜ 0.01), closed-cell designed stents (31% vs. 51% with open-cell stent) during CAS and selective shunting (6% vs. 16% of routine shunting, P ＜ 0.01) during CEA were protective factor of NBLs. In this study, CAS resulted in higher incidences of NBLs compared with CEA (53% vs. 24%, P = 0.002). However, the significance of microemboli is an unanswered question, currently. In a 2-year prospective study, 90% of the events were clinically silent [27] .
A large prospective, population-based study demonstrated that elderly people with silent brain infarcts on MRI are associated with higher risk of dementia and a steeper decline in cognitive function [28] . However, there are few studies investigating the relation between external cranial carotid artery revascularization and neuropsychological dysfunction [29, 30] . Regarding the effect on cognitive function, microembolism during procedure may induce adverse effects while possibly inducing positive effects by increasing brain perfusion. For this question, further study is needed.
The debate as to whether CAS is an alternative to CEA is ongoing. Our results showed unacceptable periprocedural stroke rates in CAS group. These results suggest that CEA should be the treatment of choice for patients with carotid artery stenosis and CAS should be performed with more restricted criteria in an experienced hospital. The limitations of this study are a retrospective design and small sample size.
CONFLICTS OF INTEREST
No potential conflict of interest relevant to this article was reported.
